Cardiovascular Disease Prevention

 

Cardiovascular Disease Prevention:

The Highest-Priority Target

Cardiovascular disease remains the leading cause of death globally, yet much of it is preventable through risk factor management. The traditional risk factors—hypertension, hyperlipidemia, diabetes, smoking, obesity, and physical inactivity—account for the vast majority of cardiovascular disease.

Blood Pressure Management: Hypertension, often called the "silent killer," typically causes no symptoms while progressively damaging arteries, heart, kidneys, and brain. Blood pressure should be checked at least annually; more frequently if elevated. Target blood pressure remains somewhat controversial, but generally systolic below 130 mmHg and diastolic below 80 mmHg for most adults. Lifestyle interventions—weight loss, sodium reduction, potassium increase, exercise, stress management, limited alcohol—often suffice for stage 1 hypertension. Medication proves highly effective when needed and dramatically reduces cardiovascular events.

Lipid Management: Cholesterol screening should begin in early adulthood and continue regularly. Focus extends beyond total cholesterol to include LDL cholesterol (the primary atherogenic particle), HDL cholesterol (generally protective), triglycerides, and increasingly, advanced lipid testing like apolipoprotein B and lipoprotein(a). Dietary changes, particularly reducing saturated fat and increasing fiber, improve lipid profiles. Statins prove remarkably effective for high-risk individuals, reducing cardiovascular events by approximately 25-35%. The decision to use medication should consider overall cardiovascular risk, not just cholesterol numbers in isolation.

Diabetes Screening and Prevention: Fasting glucose and hemoglobin A1C tests screen for diabetes and prediabetes. Screening should begin by age 45 or earlier if risk factors present. Prediabetes affects approximately one-third of adults and strongly predicts future diabetes—but lifestyle intervention can prevent or delay progression. Weight loss of 5-10%, regular exercise, and dietary improvement reduce diabetes incidence by approximately 58% in high-risk individuals. For established diabetes, tight glucose control prevents complications affecting eyes, kidneys, nerves, and cardiovascular system.

Emerging Cardiovascular Risk Markers: Beyond traditional risk factors, several emerging markers warrant consideration. High-sensitivity C-reactive protein (hs-CRP) measures inflammation predicting cardiovascular events. Coronary artery calcium (CAC) scoring via CT scan directly visualizes arterial calcification, providing powerful risk stratification, though involves radiation exposure. Lipoprotein(a), a genetically determined risk factor, can be measured once—if elevated, it intensifies need for aggressive management of modifiable risk factors. These tests aren't routine for everyone but help clarify risk in intermediate-risk individuals guiding treatment intensity.

Cancer Screening: Early Detection Saves Lives

Cancer screening aims to detect malignancy at early, curable stages. However, screening's benefits must be balanced against harms including false positives, overdiagnosis (detecting cancers that wouldn't cause problems), and test complications. Recommendations balance these considerations:

Colorectal Cancer Screening: Among the most effective cancer screenings, preventing cancer through polyp removal while detecting existing cancers early. Multiple options exist: colonoscopy every 10 years (gold standard, allows immediate polyp removal), flexible sigmoidoscopy every 5 years, CT colonography every 5 years, and stool-based tests (FIT or multi-target DNA tests) annually or every 1-3 years. Screening should begin at age 45 for average-risk individuals; earlier if family history or other risk factors present. Continue until age 75; individual decision between 75-85; generally discontinue after 85.

Breast Cancer Screening: Mammography reduces breast cancer mortality by detecting cancers early. Women should begin screening between ages 40-50 based on individual risk factors and preferences, continuing biennially or annually through at least age 74. Those at high risk (strong family history, genetic mutations) may benefit from earlier, more frequent screening and MRI addition. Breast self-awareness (noting changes) matters, though formal self-examination teaching no longer recommended.

Cervical Cancer Screening: Pap smears and/or HPV testing effectively prevent cervical cancer. Women should begin screening at age 21, with frequency depending on age and test type: Pap alone every 3 years (ages 21-29), Pap plus HPV test every 5 years or Pap alone every 3 years (ages 30-65). Screening can generally stop at age 65 after adequate negative results. HPV vaccination dramatically reduces cervical cancer risk; currently recommended for all individuals through age 26, with catch-up vaccination to age 45 based on individual circumstances.

Prostate Cancer Screening: Prostate-specific antigen (PSA) testing remains controversial due to overdiagnosis concerns and unclear mortality benefit. Men ages 55-69 should discuss screening with physicians, making individual decisions based on preferences and risk factors. Generally not recommended before 55 or after 70, though high-risk individuals (African American men, strong family history) may benefit from earlier initiation.

Lung Cancer Screening: Annual low-dose CT screening is recommended for adults ages 50-80 with 20 pack-year smoking history who currently smoke or quit within the past 15 years. This screening reduces lung cancer mortality by approximately 20% but involves radiation exposure and false positive rates requiring careful patient selection and high-quality screening programs.

Other Cancers: Routine screening for other cancers (ovarian, pancreatic, liver, etc.) isn't currently recommended for average-risk individuals due to insufficient evidence of benefit. However, those at high risk due to genetic syndromes, strong family history, or specific exposures may benefit from specialized surveillance programs.

Bone Health and Osteoporosis

Osteoporosis, characterized by decreased bone density and increased fracture risk, affects approximately half of women and a quarter of men over age 50. Hip and spine fractures dramatically impact mortality, independence, and quality of life. Prevention begins in youth through calcium and vitamin D intake, weight-bearing exercise, and avoiding smoking and excessive alcohol.

Bone density screening via DEXA scan is recommended for women at age 65 and men at age 70, or earlier if risk factors present. Those with osteoporosis or significant osteopenia benefit from treatment with bisphosphonates or other medications dramatically reducing fracture risk. Adequate calcium (1000-1200mg daily from food and supplements), vitamin D (800-1000 IU daily, more if deficient), weight-bearing exercise, and fall prevention strategies all preserve bone health.

Vision and Hearing: Sensory Health Matters

Vision and hearing loss accelerate cognitive decline, increase fall risk, reduce quality of life, and promote social isolation. Regular screening allows early detection and treatment.

Vision: Annual eye exams detect refractive errors, cataracts, glaucoma, macular degeneration, and diabetic retinopathy. Many of these conditions progress silently until advanced. Comprehensive exams by optometrists or ophthalmologists should occur at least every 1-2 years after age 60, more frequently if risk factors present. Early treatment of glaucoma and macular degeneration can preserve vision.

Hearing: Hearing loss affects approximately two-thirds of adults over 70, yet only a quarter use hearing aids. Untreated hearing loss associates with cognitive decline, dementia, depression, and social isolation. Hearing should be tested at least every few years after age 50. Modern hearing aids prove far superior to older models; don't let outdated perceptions prevent treatment. Protecting hearing from loud noise exposure prevents damage accumulating over time.